Who Paid My Doc
Rezum II Pivotal Study
ClinicalTrials.gov NCT01912339
Research payments
$238,033
Through program year 2021, $238,033 in research payments was reported against Rezum II Pivotal Study, across 56 payments, paid by Boston Scientific Corporation.
- Paid by
- Boston Scientific Corporation
- ClinicalTrials.gov
- NCT01912339
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $5,690 | 3 |
| 2020 | Research | $26,619 | 17 |
| 2019 | Research | $205,724 | 36 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Richard Levin Towson, MD Named on 9 payments
- Stephen Richardson Salt Lake City, UT Named on 5 payments
- Marc Gittelman Miami, FL Named on 4 payments
- Igor Dumbadze Cincinnati, OH Named on 3 payments
- David Prall Saint Paul, MN Named on 3 payments
- Steven Gange Salt Lake City, UT Named on 3 payments
- Neal Shore Myrtle Beach, SC Named on 3 payments
- Lance Mynderse Rochester, MN Named on 3 payments
- Kalpesh Patel Paradise Valley, AZ Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.